[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]  BowTiedBiotech 🧪🔬🧬 [@BowTiedBiotech](/creator/twitter/BowTiedBiotech) on x 19.6K followers Created: 2025-07-09 11:02:31 UTC 5/ Hidden Insight: This Isn’t Just About COPD Ohtuvayre is approved for COPD maintenance therapy, but Merck’s language hints at broader ambitions. What to potentially watch: 🔹Asthma 🔹Bronchiectasis 🔹Long-COVID 💡Prediction: This becomes a pipeline-in-a-drug with label expansion trials starting in 2026.  XXXXX engagements  **Related Topics** [prediction](/topic/prediction) [approved](/topic/approved) [Post Link](https://x.com/BowTiedBiotech/status/1942902180912013324)
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
BowTiedBiotech 🧪🔬🧬 @BowTiedBiotech on x 19.6K followers
Created: 2025-07-09 11:02:31 UTC
5/ Hidden Insight: This Isn’t Just About COPD
Ohtuvayre is approved for COPD maintenance therapy, but Merck’s language hints at broader ambitions.
What to potentially watch: 🔹Asthma 🔹Bronchiectasis 🔹Long-COVID
💡Prediction: This becomes a pipeline-in-a-drug with label expansion trials starting in 2026.
XXXXX engagements
Related Topics prediction approved
/post/tweet::1942902180912013324